Association of Roxadustat Versus Erythropoiesis-Stimulating Agents With Renal Outcomes in Non-Dialysis CKD: A Propensity-Matched Real-World Cohort Study
Association of Roxadustat Versus Erythropoiesis-Stimulating Agents With Renal Outcomes in Non-Dialysis CKD: A Propensity-Matched Real-World Cohort Study. // Clinical Therapeutics. – URL: https://www.sciencedirect.com/science/article/pii/S0149291826002328?dgcid=rss_sd_all
Association of Roxadustat Versus Erythropoiesis-Stimulating Agents With Renal Outcomes in Non-Dialysis CKD: A Propensity-Matched Real-World Cohort Study. Clinical Therapeutics. https://www.sciencedirect.com/science/article/pii/S0149291826002328?dgcid=rss_sd_all
“Association of Roxadustat Versus Erythropoiesis-Stimulating Agents With Renal Outcomes in Non-Dialysis CKD: A Propensity-Matched Real-World Cohort Study.” Clinical Therapeutics.
@article{article41656,
title = {Association of Roxadustat Versus Erythropoiesis-Stimulating Agents With Renal Outcomes in Non-Dialysis CKD: A Propensity-Matched Real-World Cohort Study},
journal = {Clinical Therapeutics},
url = {https://www.sciencedirect.com/science/article/pii/S0149291826002328?dgcid=rss_sd_all}
}